A method and apparatus for detection of pteridine levels in a biological sample using CE-LIF which is useful for early cancer screening involving fully oxidizing pteridine compounds in a sample such as a urine sample, subjecting to CE-LIF to assess compound concentration, and compare to expected levels in for healthy or cancer-bearing patients.
Y. Ma and S. Gibbons, "Method and Apparatus for Cancer Screening," U.S. Patents, Dec 2015.
Patent Application Number
© 2010 The Curators of the University of Missouri, All rights reserved.
08 Dec 2015